Clinical Study Protocol ARTICLE
A Cross-sectional Survey and Cross-sectional Clinical Trial to Determine the Prevalence and Management of Eye Movement Disorders and Vestibular Dysfunction in Post-Stroke Patients in the Sub-Acute Phase: Protocol
- 1Department of Physiotherapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
- 2Faculty Research Office, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
- 3Department of Speech-Language Pathology and Audiology, Faculty of Humanities, University of Pretoria, Pretoria, South Africa
Introduction: Visual impairment, specifically eye movement disorders and vestibular dysfunction may have a negative influence on the functional recovery in post-stroke patients. This type of sensory dysfunction may further be associated with poor functional outcome in patients’ post-stroke.
Methods: In phase 1, a cross-sectional survey (n = 100) will be conducted to determine the prevalence of eye movement disorders and vestibular dysfunction in patients who sustained a stroke. A cross-sectional clinical trial (n = 60) will be conducted during phase 2 of the study to determine the effect of the combination of vestibular rehabilitation therapy (VRT) and visual scanning exercises (VSE) (experimental group) integrated with task-specific activities compared with the effect of task-specific activities as an intervention (control group) on patients who present with eye movement impairment and central vestibular dysfunction post-stroke. An audiologist will assess (a) visual acuity (static and dynamic), (b) nystagmus, (c) saccadic eye movements, (d) smooth pursuit eye movements, (e) vestibulo-ocular reflex, and (f) saccular, utricular, and vestibular nerve function. An independent physiotherapist will assess (1) cognitive function, (2) residual oculomotor visual performance, (3) visual–perceptual system, (4) functional balance, (5) gait, (6) functional ability, (7) presence of anxiety and/or depression, and (8) level of participation in physical activity.
Ethics and dissemination: Ethics approval has been obtained from the Ethics Committee of the Faculty of Health Sciences at the University of Pretoria (UP) (374/2015). The study will be submitted as fulfillment for the PhD degree at UP. Dissemination will include submission to peer-reviewed professional journals and presentation at congresses. Training of rehabilitation team members on the integration of VSE and VRT into task-specific activities in rehabilitation will be done if the outcome of the experimental group’s functional performance is clinically and statistically significantly better than the control group on the Barthel Index.
Trial Registration: Pan African Clinical Trials Registry (PACTR201509001223262).
A recent Cochrane review of interventions for eye movement disorders in post-stroke patients concluded that “eye movement disorders may affect over 70% of stroke patients” (1). Eye movement disorders may result in (a) “difficulty maintaining the normal ocular position” (1) and (b) “difficulty moving the eyes appropriately” (ocular motility) (1). Difficulty in “maintaining the normal ocular position” may result in disconjugate eye movement (eyes do not move in the same direction and by equal amount) (1, 2); strabismus (one eye or both eyes deviate so the eyes are no longer aligned); and/or nystagmus (frequent involuntary oscillations and other random eye movements) (1). Difficulty with spontaneous and voluntary movement of the eyes appropriately during functional activities may include impairment of (i) saccadic eye movements (1) [rapid eye movements (400°–600°/s) that shifts the eyes from one target to another] (1, 2), (ii) smooth pursuit eye movements [slow movement of the eyes (1°–30°/s) that serve to keep gaze on a moving visual object of interest when the head is stationary] (3–5), (iii) fixation (ability to maintain a steady eye position on a target) (1), (iv) convergence (the ability to smoothly and automatically turn the eyes in along the midline to observe near objects with single vision) (6), (v) divergence (to turn the eyes outward for single vision of distant objects) (6), (vi) vestibulo-ocular reflex (to ensure stable images on the retina and clear vision during head movements) (1, 2, 7, 8), and (vii) palsy (inability to use the ocular muscles that move the eye horizontally or vertically) (1, 2). Ocular motility and the interpretation of the visual input gathered during eye movements are important for aligning and maintaining the body in space which is fundamental to the successful performance of functional tasks in any particular environment (9).
The anatomical location of the lesion following a hemispheric, subcortical, brainstem or cerebellar stroke may result in the following symptoms (2): (a) posterior parietal cortex [unilateral spatial neglect (USN); impaired eye movements to the contralesional hemifield], (b) posterior occipito-temporal cortical areas (visual field defect; homonymous hemianopia; abnormal eye movement into the hemianopic visual field; USN), (c) frontal lobe (saccadic eye movement and smooth pursuit eye movement dysfunction), (d) basal ganglia [impaired saccadic- and smooth pursuit eye movements; impaired convergence; USN (visual and auditory neglect)], (e) thalamus (conjugate gaze deviation contralateral to the side of the lesion; abnormal subjective visual vertical; inaccurate saccadic eye movements; USN), (f) brainstem (conjugate gaze abnormalities), and (g) cerebellum (impaired smooth pursuit eye movements and VOR suppression; gaze-holding dysfunction; ataxia of the head, trunk, and limbs) (2).
Visuomotor deficits and visual–perceptual impairments as result of eye movement disorders may affect an individual’s ability to respond to sensory input obtained from the environment and demands of the task. The inability to respond efficiently upon the sensory input from the environment and demands of the task results in a change (decrease) in postural control that leads to increased functional dependence during ADL and disability (6, 10). Clinical observations of patients with eye movement disorders following a stroke may include the following (1, 6): (1) head turn or head tilt during near (close-up) tasks, (2) avoidance of near (close-up) tasks, (3) seems to look past the observer, (4) closing or covering one eye during conversations and/or activities due to blurred vision or double-vision, (5) squinting, (6) rubs eyes a lot, (7) having difficulty maintaining eye contact, (8) neglecting one side of the body or space during functional activities, (9) bumping into walls or objects during walking or when maneuvering in a wheelchair, (10) appears to misjudge distance due to a loss of depth perception, (11) difficulty with activities of daily living due to poor eye-hand coordination – knocking objects over or missing objects during reaching, (12) “under reaching” or over reaching for objects, (13) decreased attention during conversations and/or activities (patient “day dreams”), (14) losing the place when reading, (15) having difficulty “seeing” with or without glasses, (16) letters jumping around on the page during reading, (17) experiencing eye strain or headaches, (18) portions of the page being missing when reading, (19) objects or portions of objects not being observed, (20) not seeing people or objects approaching suddenly from one side, and (21) having difficulty concentrating on tasks.
Although the association between visual impairment and impaired functional ability is recognized, “the services available to patients with visual impairment following stroke are inconsistent at present” (1). A significant proportion of patients following a stroke may present with unrecognized eye movement disorders and thus receive minimal management of their visual impairment during rehabilitation that has a wide-ranging impact on their functional performance (1, 11). The authors of the Cochrane review (1) found only two studies that investigated interventions for eye movement disorders; both of these randomized controlled trials investigated the effect of pharmacological intervention and not rehabilitation. The authors in both studies concluded that “there is insufficient evidence to reach a conclusion regarding the effectiveness of the different interventions for patients with eye movement disorders after stroke” (1). Pollock et al. (1) also considered possible management of patients with eye movement disorders that included (1) restitutive intervention that includes saccadic eye movement, smooth pursuit eye movement, and convergence training, (2) compensative intervention that consists of training of eye movements for reading, compensatory head movements, and training in ADL, and (3) standardized diagnostic assessment and management of the visual impairment following the stroke (1).
Results of a matched-pair randomized controlled trial conducted by Van Wyk et al. (12) indicated that visual scanning exercises (VSE) with saccadic eye movement training during task-specific activities for patients with USN following a stroke resulted in significant improvement on impairment and functional activity level after 4 weeks of rehabilitation. However, the authors realized that although the intervention focused on the visual system (VSE integrated with task-specific activities), the visual system also functions in intimate integration with the vestibular system and the somatosensory (proprioceptive, cutaneous, and joint receptors) systems in maintaining postural orientation and stability during functional movement.
Patients with vestibular dysfunction experience symptoms may include (1) visual blurring with head movement, (2) subjective complaints of dizziness and/or imbalance, (3) postural instability, (4) balance dysfunction, (5) increased sway in standing, (6) dysregulated gait, (7) falling, and (8) fear of falling as a result of impaired vestibulo-spinal reflexes, vestibulo-ocular reflexes (VORs), and abnormally activated vestibulo-thalamo-cortical pathways that may result in functional impairments in daily life (13–16). Various interventions that include (a) virtual reality, (b) vibrotactile feedback, (c) optokinetic stimulation, (d) VOR adaptation and saccadic exercises, and (e) gait and balance training have shown to decrease dizziness and improve postural control in patients with peripheral and central vestibular disorders (14). Although vestibular rehabilitation therapy (VRT) is indicated in patients with central and peripheral vestibular dysfunction (14), it is recommended that “enhanced engagement with physical, cognitive, and social stimulation that include novel and multi-modal stimulation result in better general functional outcomes” (13). Another recommendation is that VRT should be patient dependent and progression of the exercises should take the individual patient’s sensorimotor, cognitive, and emotional profiles into account (13, 14, 16).
Growing evidence exists that the central nervous system has the ability to compensate for vestibular impairment and re-weight sensory information (16). Although a recent Cochrane review (17) and other literature (16, 18) reported moderate to strong evidence to support VRT for persons with vestibular dysfunction, the assessment and management of central vestibular dysfunction are not integrated in standard post-stroke rehabilitation but occasionally treated as a separate problem. Limited evidence on the prevalence of (a) visual impairments specifically eye movement disorders and (b) central vestibular dysfunction in patients post-stroke has been identified in the literature. The researcher therefore identified a need to investigate the prevalence of specifically eye movement disorders and central vestibular dysfunction in the sub-acute post-stroke population. Identification of possible presence of visual impairments and central vestibular dysfunction in the post-stroke population may facilitate the development of evidence-based treatment for patients with visual impairment and central vestibular dysfunction following stroke.
There is further a lack of research evidence on the combination of VRT and VSE as part of, and integrated with task-specific activities (the gold standard in post-stroke rehabilitation), on body impairment level, functional activity, and participation levels in the treatment of post-stroke patients. The long-term effect of VSE and VRT integrated with task-specific activities on patients’ activities related to participation also needs to be investigated.
Methods and Analysis
A cross-sectional survey will be conducted during phase 1 of the study to determine (1) the prevalence of visual impairments and central vestibular dysfunction in patients who are in the sub-acute phase post-stroke and (2) whether there is an association between the prevalence of visual impairments and central vestibular dysfunction in sub-acute post-stroke patients’ (a) cognitive function, (b) residual oculomotor visual performance, (c) visual–perceptual system, (d) functional balance, (e) gait, (f) functional ability, and (g) presence of anxiety and/or depression. The STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) checklist will be used when reporting the results of the cross-sectional survey.
A cross-sectional clinical trial will be conducted during phase 2 of the study to determine the effect of the combination of VRT and VSE integrated with task-specific activities received by patients (Group 1) in the sub-acute phase post-stroke compared with patients who received task-specific activities alone (Group 2) on their: (a) visual impairments, (b) central vestibular dysfunction, (c) cognitive function, (d) visual–perceptual function, (e) residual oculomotor visual performance, (f) functional balance, (g) functional ability, (h) gait, and (i) level of anxiety and/or depression. The duration of the intervention period will be 2 weeks. The long-term effect of the two interventions on patients’ participation in physical activity 20 weeks after rehabilitation has been terminated will also be determined. The CONSORT statement will be used when reporting the results of the cross-sectional clinical trial.
The study will be conducted at private and public rehabilitation institutions in Pretoria and Johannesburg, Gauteng, South Africa. Patients will be referred by multiple acute private and public health-care settings to the appropriate rehabilitation centers.
All patients who sustained a cerebral vascular incident (CVI), who are in the sub-acute phase post-stroke, and who will be admitted at one of the rehabilitation settings in Pretoria and Johannesburg, Gauteng, South Africa will be eligible to participate in the study. A CVI is defined as “the presence of a focal neurological defect due to vascular cause that is present 24 h” and results in varying degrees of dysfunction in activities of daily living (19). The sub-acute phase post-stroke is defined as the period of time since a patient is physiologically stable to 6 months post-stroke (19).
Eligibility Criteria: Inclusion Criteria
Inclusion criteria for participants in the first phase of the trial will entail:
(a) Patients who suffered either an ischemic or hemorrhagic stroke (20) clinically diagnosed by a medical specialist (neurologist). Information on the type of stroke will be obtained from the patients’ medical records.
(b) Male and female patients in the age group of 19–84 years (21).
(c) Minimum Mini-Mental State Examination (MMSE) score of 7 (22).
In phase 2 of the study, patients will have in addition to these criteria also have to be diagnosed with visual impairments and/or central vestibular dysfunction.
Eligibility Criteria: Exclusion Criteria
Patients with the following characteristics will be excluded from the trial:
(a) Severe dementia, identified by implementing the MMSE (22).
(b) History of an organic disorder or major psychiatric impairment (20).
(d) Positive Dix–Hallpike test (to exclude BPPV of posterior and anterior SCCs).Because the Dix–Hallpike test and CRT (Epley) maneuver require the head rotation of 45° and the extension of 20° to 30°, patients with a history of neck surgery, recent neck trauma, severe rheumatoid arthritis, atlanto-axial and occipito-atlantal instability, cervical myelopathy or radiculopathy, carotid sinus syncope, Chiari malformation, and vascular dissection syndromes will be excluded from the study (24).
(e) Positive Roll test (to exclude BPPV of horizontal SCCs).
(f) Participation in other pharmacological or rehabilitation intervention studies which can confound the results of this study (20).
In phase 2 of the study, the same inclusion/exclusion criteria will be applicable as in phase 1 since patients will be randomly recruited from patients assessed in phase 1 of the study.
The sample size of phases 1 and 2 are interrelated and was calculated simultaneously with the assistance of a statistician. All patients who suffered a stroke and will be admitted at one of the pre-selected rehabilitation hospitals in Pretoria and Johannesburg, Gauteng for rehabilitation in the sub-acute phase will be assessed to determine if they meet the inclusion and exclusion criteria of the study. Recruitment and assessment of patients will be done in each of the rehabilitation centers in a consecutive sequence based on the number of patients in a particular center at a given time until an adequate and representative sample group (n = 100) for the trial has been reached. An adequate and representative sample size required for phase 1 of the study was calculated based on a relatively small, but similar study (12). These authors reported the geometric mean and 95% confidence interval (CI) at baseline and the end of each week of the treatment period. The expected geometric mean of the Barthel Index value at onset was 45 (12) and an improvement in the change from baseline at 2 weeks for the combination of VSE integrated with task-specific activities group (experimental group) compared with the task-specific activities group (control group) is 36 which is 0.214 on the logarithmic (base 10) scale. From the reported 95% CI for the geometric mean, a SD of 0.179 on the log scale was calculated. Since a change from baseline of interest, this SD was inflated by a factor (√2 to 0.249). Based on this information, a sample of at least 30 patients per group will have 90% power to detect the clinical relevant change when testing at the 0.05 level of significance. If testing was one-sided (VRT, VSE, and task-specific activities), based on the published results of the previous study (12), a sample of 30 patients per group will be required. Hence, to achieve a sample size of 30 patients per group, the cross-sectional part of the study (phase 1) will need to enrol at least 100 patients in the sub-acute phase. Prevalence of visual impairments and central vestibular dysfunction will be of interest. As the latter is expected to be in excess of 70% the above sample size is adequate to estimate the prevalence’s to an accuracy within 10%. One hundred patients who meet the eligibility criteria and will give written informed consent to participate in the study will therefore be included in phase 1 of the trial.
Data Collection Procedure
Cross-Sectional Survey: Phase 1 of the Study
One hundred (n = 100) patients, who meet the eligibility criteria, in the research settings will be recruited for possible participation in the study. Data collection in phase 1 will be done at each of the research settings for an estimated period of 4 weeks/rehabilitation setting. Each patient who meets the eligible criteria for phase 1 in a particular setting and who will give informed consent after a thorough explanation of what the study will entail will be included into the study and undergo the battery of audiological and physiotherapy assessment procedures (Table 1). The patients will also be informed that participation in the trial is voluntary and they are free from undue coercion. In this study, the International Classification of Functioning, Disability and Health (ICF) (25) is used as the model of disablement within which the patients’ levels of impairment, functional activity, and participation will be determined and documented. Collection of comprehensive demographic information relating to age, gender, race, affected side post-stroke, dominant side prior to stroke, stroke type, type of residence, level of education, and type of work will be collected from patients. Thereafter, an audiologist will assess (a) visual acuity (static and dynamic), (b) nystagmus, (c) saccadic eye movements, (d) smooth pursuit eye movements, (e) vestibulo-ocular reflex, and (f) saccular, utricular, and vestibular nerve function. A physiotherapist who is not involved in the treatment of these patients will assess (1) cognitive function, (2) residual oculomotor visual performance, (3) visual–perceptual system, (4) functional balance, (5) gait, (6) functional ability, and (7) presence of anxiety and/or depression in these patients. If a specific eye condition or eye disease is suspected, the patient will be referred to an ophthalmologist for ophthalmologic assessment and management. The battery of valid and standardized outcome measures that will be completed by a qualified audiologist and physiotherapist (who will not be involved in the allocation of the patients to the experimental and control groups nor the intervention) is summarized in Table 1. The qualified audiologist and physiotherapist will complete the battery of outcome measures over a 2-day period to minimize possible performance fluctuations due to fatigue as result of the lengthy test protocol.
Table 1. The battery of valid and standardized outcome measures that will be completed by a qualified audiologist and physiotherapist.
Cross-Sectional Clinical Trial: Phase 2 of the Study
Patients with or without visual impairment and/or vestibular dysfunction will be identified based on the results of patients’ diagnosis after the battery of standardized outcome measures has been completed by two independent assessors (audiologist and physiotherapist) during phase 1 of the study. Sixty patients with (visual and/or vestibular dysfunction) identified in phase 1 of the study will be recruited to participate in the second phase of the study and randomly allocated to either Group 1 or Group 2. The study population will include the data of the first 30 patients in each group who participate in the study for all 20 weeks. The two groups of 30 patients in the respective group do not make provision for drop out of participants in the study. If patients leave the study for any reason, they will have to be replaced by another patient. The results of this first battery of tests (phase 1) will serve as the baseline measurements for phase 2 of the study. In phase 2, the researcher will determine the effect of the combination of VRT and VSE integrated with task-specific activities (n = 30) as an intervention approach for patients in the sub-acute phase post-stroke compared with patients who will receive task-specific activities (n = 30) alone as an intervention approach on their: (a) visual impairments, (b) central vestibular dysfunction, (c) cognitive function, (d) residual oculomotor visual performance, (e) visual–perceptual system, (f) functional balance, (g) ability to modify gait in response to changing task demands, (h) functional ability, and (i) presence of anxiety and/or depression after the intervention period of 2 weeks. The consecutive assessment will be repeated by the two independent assessors after the 2-week intervention period. Twenty weeks after rehabilitation has been terminated, the physiotherapist (independent assessor) will contact all patients who completed phase 2 of the study, to complete the Telephonic-Administered International Physical Activity Questionnaire (IPAQ). The aim will be to determine the effect of the combination of VRT and VSE integrated with task-specific activities for patients in Group 1 (experimental group), compared with patients who will receive task-specific activities alone Group 2 (control group) on patients’ participation activities 20 weeks after rehabilitation has been terminated.
Patients will receive intervention daily for a period of 2 weeks. The period of intervention consisting of 2 weeks was selected due to the fact that patients are on average admitted to a private rehabilitation setting post-stroke for a period of 2 weeks. The intervention period of 2 weeks were further decided upon because results from a previous study (12) demonstrated a statistically significant (p = 0.02) difference between Group 1 and Group 2 after 2 weeks intervention (12). Any adverse effects within the period of 20 weeks will be documented.
Patients in the experimental group will receive a combination of VRT and VSE integrated with task-specific activities as part of the treatment as an “add on” intervention in this trial. A guide on the principles of VSE integrated with task-specific activities and the principles of progression of these exercises (12) is described in Table 2.
Table 2. Guide of the principles of saccadic eye movement training with visual scanning exercises integrated with task-specific activities and the principles of progression of these exercises (12).
Vestibular rehabilitation therapy for treatment of central vestibular dysfunction consists of a program of exercises designed to (i) facilitate adaptation of the vestibular system, (ii) habituate the person to movement, (iii) teach sensory substitution, and (iv) as such improve a person’s balance and postural control (50).
Vestibular Adaptation Exercises
“Vestibular adaptation refers to the long-term changes” that take place in the vestibular system in response to stimuli that induce adaptation (51). The preferred stimuli to facilitate adaptation are to produce an error signal that the CNS attempts to decrease by modifying the gain of the vestibular system (51). Gaze-stabilization exercises to retrain VOR function are prescribed to stimulate retinal slip to optimize vision during head movement and as such to achieve vestibular adaptation. The first exercise consists of having the patient focus on a target while moving their head as fast as they can and still maintain fixation on the target. The exercise is performed in various functional positions, during gait, walking with a different speed, against various backgrounds, at different distances from the target and in different planes of movement (14, 16). The second exercise consists of having the patient focus on a target while the target and the head move in opposite directions while the patient keeps the target in focus by maintaining visual fixation on the target (51). The exercise is performed in various functional positions, during gait, walking with a different speed, against various backgrounds, during different distances and in different planes (14, 16).
The purpose of habituation exercises is to facilitate a reduction in symptoms through repetitive exposure and practice of a movement that provokes the symptoms experienced by the patient. The aim of habituation exercises is to “de-sensitize” the patient and to improve motion-induced dizziness or vertigo (18, 50, 51). Positions and movements may include moving from sitting to lying in supine, rolling from supine to left side lying, rolling from supine to right side lying, moving from supine to sitting, moving from sitting to left and right Dix–Hallpike position, return to sitting from the Dix–Hallpike position, horizontal and vertical movement of the head and turning 180° to the left and right (51).
Saccadic eye movement substitution is another method that is aimed to decrease visual blurring and dizziness (14). Errors in gaze position were reduced when compensatory saccadic eye movements were utilized as part of the gaze-stabilization process. The combination of decreased retinal slip and saccadic eye movement substitution may improve visual blurring during active head motion (14). Whitney et al. (16) recommend that “exercises to increase trunk and head movement are encouraged to improve the VOR-gain and to improve overall gait function” (16). The purpose of substitution exercises is to integrate visual and somatosensory information with vestibular input to improve gaze and postural stability (51). The rehabilitation program may include substitution exercises that alter somatosensory cues, for example, let the patient stand on different surfaces, i.e., foam with eyes open and closed; challenges the vestibular system by letting the patient perform activities with and without visual input; modified center of gravity exercises; and weight shifting (16). By removing or altering visual/somatosensory cues, the patient is forced to use remaining sensory–motor cues which will result in the fostering of responses by reacting on mainly vestibular cues (51).
Improve an Individual’s Balance and Postural Control
A comprehensive exercise program includes higher-balance activities that are practiced under supervision of a physiotherapist. Standing and walking exercises are progressed by changing the patients’ base of support and speed at which activities are performed (50). Progression to dual-task activities is incorporated within safety limits as the patients’ postural control (observed as improved functional ability) improves.
The principal investigator will treat all patients in the experimental group within the rehabilitation hospital settings and will therefore be aware of participant allocation. Due to the fact that rehabilitation is a multidisciplinary team approach, the patients who participate in the clinical trial will continue to be treated by other members of the multidisciplinary team, namely, the occupational therapist, the speech and language therapist, social worker, and psychologist as it is customary in the relevant rehabilitation hospital settings.
The task-specific approach to rehabilitation is the standard of care intervention approach (10). An example of the flow of a therapy session based on the task-specific approach (12, 52) is described in Table 3.
Patients in Group 2 will be treated by qualified physiotherapists within the rehabilitation centers. These therapists will use the same task-specific principles in the rehabilitation of post-stroke patients as the researcher. The researcher will ensure the physiotherapists who are employees of the different rehabilitation settings are familiar and implement the same task-specific principles as the researcher treating the experimental group.
The course of the study is displayed in Figure 1.
Quality Control (Bias Protection)
All tests, completed by the audiologist and outcome measures and the physiotherapist, are internationally recognized and validated tests and outcome measures. The results of this trial may therefore be compared with studies where similar data collection methodology has been applied on both national and international level. To prevent selective assessment bias, the two independent assessors (a qualified audiologist and physiotherapist) will be blind with regard to the group that the patients will be assigned to. The physiotherapist who will conduct the assessments will be an independent assessor and not the principal investigator. The patients will be blind to the group they are assigned to. The researcher will ensure the physiotherapists treating the control group are familiar and implement the same task-specific principles as the researcher treating the experimental group. The principal investigator completed a workshop on Good Clinical Practice Guidelines presented by the UP in July 2015 (GCP 2015/07-002).
Data Management and Analysis
Data of the cross-sectional survey (phase 1 of the study) will be analyzed and reported according to the STROBE checklist. Data of the cross-sectional clinical trial (phase 2 of the study) will be analyzed and reported according to the CONSORT statement. The outcomes measures measuring the clinical outcomes the data summary will make use of descriptive statistics, geometric mean, SD, median, range, and 95% CIs will be used when data conforms to a Gaussian distribution. Results from the two groups will be compared with respect to outcome at 2 weeks, adjusted for baseline values, using analysis of covariance (ANCOVA), using ranks when data are skewed. Data characteristics permitting, groups may also be compared using a mixed-model approach which will indicate the data over all the time points where treatment, time, and treatment–time interaction will be entered into the model, and the treatment–time interaction will be of primary intent. Testing will be done at the 0.05 level of significance.
Ethics Considerations and Dissemination
Ethics approval has been obtained from the Ethics Committee of the Faculty of Health Sciences at the UP (374/2015) after approval of the research protocol by the post-graduate committee of the School of Healthcare Sciences, UP. The study has been registered at the Pan African Clinical Trials Registry (PACTR201509001223262). The fact that patients in Group 1 will receive intervention (VRT and VSE integrated with the task-specific activities) that patients in Group 2 will not receive, can ethically be accounted for because VRT and VSE integrated with the task-specific activities is not part of the present standard rehabilitation protocol that patients receive at the rehabilitation centers. Patients in Group 2 will therefore not be deprived of treatment that they would have received in these rehabilitation hospital centers. Patients in the experimental group will receive VRT and VSE integrated with the task-specific activities as “add on” activities. A study on the effect of VSE on the outcome of functional rehabilitation revealed that the intervention (VSE integrated with the task-specific activities) is not harmful to patients in any way (4).
Patients will be informed that their rehabilitation is part of a clinical trial. The procedures will be explained to them carefully in a way that they will understand. An information sheet and informed consent form with the clear explanation of what the study entails will be given to all prospective patients prior to commencement of the study. The patients will be provided with all information necessary to make a well-informed decision. The patient will also be informed that involvement in the study is voluntary, and she/he may leave the study at any time. The withdrawal from the study will not affect patients’ treatment at the rehabilitation center that they were admitted to. Information on each patient will be kept confidential. The information obtained will under no circumstances be disclosed to any other parties than the principal investigator and the research supervisor. Information obtained during the study will only be used for research purposes. Each informed consent form will be signed by the participant or a thumbprint if the participant is unable to write and to witnesses. The patients will only be identified by a code number allocated to them at the beginning of their participation in the study. This number will be entered into the data sheets to ensure complete confidentiality. Data will be stored on the electronic data management system of the UP, Alfresco, for a period of 15 years.
The study will be completed by the principal investigator and will be submitted as fulfillment for the PhD degree at the UP. The completed research articles will be submitted for the publication in peer-reviewed professional journals nationally and internationally. The results of this study will also be presented at various national and international congresses.
Training or/reporting to staff members at the different rehabilitation hospital settings on the integration of VSE and VRT into task-specific activities in rehabilitation will be done if the outcome of the experimental group is clinically and statistically significantly better than the results of the control group. If requested, a copy of the research article/the outcome of the study will be made available to all patients of the study. Patients who were allocated to the control group will receive the opportunity to receive VRT and VSE integrated with the task-based treatment approach received by the experimental group.
Strengths and Limitations of this Study
Strengths of the Study
• A multicentre cross-sectional survey and cross-sectional clinical trial will be combined.
• Assessment of N = 100 stroke patients in the sub-acute phase will be completed at private and public rehabilitation settings in Johannesburg and Pretoria (multicentre).
• All tests completed by the audiologist and outcome measures and the physiotherapist are internationally recognized and validated. The results of this study may therefore be compared with similar studies where the same data capturing methods or outcomes measures have been implemented on both national and international level.
• To prevent selective assessment bias, the two independent assessors (a qualified audiologist and physiotherapist) will be blind with regard to the group that the patients will be assigned to.
• The physiotherapist who will conduct the assessments will be an independent assessor and not the principal investigator.
• The patients will be blind to the group they are assigned to.
• First inter-disciplinary study conducted by the Department of Physiotherapy and Department of Audiology at the University of Pretoria (UP), South Africa.
• Equipment that will be used during the duration of the study will be provided by “Interacoustics” and specifically the “EyeSeeCam vHIT” will be utilized in a research project for the first time in South Africa.
• The proposed study is a “follow-up” study of a previously published research: Van Wyk et al. (12).
Limitations of the Study
• Upon completion of the previous study by the authors, a large number of drop out of participants after discharge from various rehabilitation settings in South Africa was observed limited long-term follow-up despite the fact that participants received remuneration for traveling costs and were contacted telephonically on a regular basis. The large loss to follow-up prevented the researcher from determining whether the long-term effect of the treatment was sustained and was regarded as a limitation of the previous study.
• Twenty weeks after rehabilitation has been terminated, the physiotherapist (independent assessor) will contact all patients who completed phase 2 of the study, to complete the Telephonic-Administered International Physical Activity Questionnaire (IPAQ) to determine the effect of the combination of VRT and VSE integrated with task-specific activities for patients in Group 1 (experimental group), compared with patients in Group 2 (control group) who will receive task-specific activities alone on their participation activities 20 weeks after rehabilitation has been terminated.
AW and Dr. CE participated in the design, coordination, and drafting of the manuscript. Prof. PB performed the statistical analysis of the sample size and data analysis. Dr. BH is a co-supervisor for the study and participated in the design of the vestibular function protocol for post-stroke patients in the sub-acute phase. She has published in the field of vestibular and neurotology and has extensive experience in vestibular testing techniques, both execution thereof and data interpretation.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The principal researcher received a National Research Foundation Innovation Doctoral scholarship for 2016 (Reference SFH150729132539) to complete this study and will be submitted as fulfillment for the PhD degree at the University of Pretoria. The principal researcher received research funding from the South African Society of Physiotherapy’s Research Foundation (VAN180).
1. Pollock A, Hazelton C, Henderson CA, Angilley J, Dhillon B, Langhorne P, et al. Interventions for disorders of eye movement in patients with stroke. Cochrane Database Syst Rev (2011) (10):CD008389. doi: 10.1002/14651858.CD008389.pub2
7. Hain TC, Helminski JO. Chapter 1. Anatomy and physiology of the normal vestibular system. 3rd ed. In: Herdman SJ, editor. Vestibular Rehabilitation. Philadelphia, PA: F.A. Davis Company (2007). p. 2–18.
9. Roller ML, Lazaro RT, Byl NN, Umphred DA. Chapter 4. Contemporary issues and theories of motor control, motor learning and neuroplasticity. 6th ed. In: Humphred DA, editor. Neurological Rehabilitation. St Louis, MO: Mosby (2013). p. 69–97.
11. Rowe F, Brand D, Jackson CA, Price A, Walker L, Harrison S, et al. Visual impairment following stroke: do stroke patients require vision assessment? Age Ageing (2009) 38:188–93. doi:10.1093/ageing/afn230
12. Van Wyk A, Eksteen CA, Rheeder P. The effect of visual scanning exercises integrated into physiotherapy in patients with unilateral spatial neglect poststroke: a matched-pair randomized control trial. Neurorehabil Neural Repair (2014) 28(9):856–73. doi:10.1177/1545968314526306
13. Lacour M, Bernard-Demanze L. Interaction between vestibular compensation mechanisms and vestibular rehabilitation therapy: 10 recommendations for optimal functional recovery. Front Neurol (2014) 5:285. doi:10.3389/fneur.2014.00285
15. Hall CD, Herdman SJ, Whitney SL, Cass SP, Clendaniel RA, Fife TD, et al. Vestibular rehabilitation for peripheral vestibular hypofunction: an evidence-based clinical practice guideline: from the American Physical Therapy Association Neurology Section. J Neurol Phys Ther (2016) 40(2):124–55. doi:10.1097/NPT.0000000000000120
19. Loetscher T, Chen C, Wignall S, Bulling A, Hoppe S, Churches O, et al. A study on the natural history of scanning behaviour in patients with visual field defects after stroke. BMC Neurol (2015) 15:64. doi:10.1186/s12883-015-0321-5
20. Blanton S, Morris DM, Prettyman MG, McCulloch K, Redmond S, Light KE, et al. Lessons learned in participant recruitment and retention: the EXCITE trial. Phys Ther (2006) 86:1520–33. doi:10.2522/ptj.20060091
21. The SASPI Project Team. Prevalence of stroke survivors in rural South Africa results from the southern Africa stroke prevention initiative (SASPI) Agincourt field site. Stroke (2004) 35:627–32. doi:10.1161/01.STR.0000117096.61838.C7
22. Hafsteinsdóttir TB, Algra A, Kappelle LJ, Grypdonck MHF, Dutch NDT Study Group. Neurodevelopmental treatment after stroke: a comparative study. J Neurol Neurosurg Psychiatry (2005) 76:788–92. doi:10.1136/jnnp.2004.042267
24. Herdman SJ, Tusa RJ. Chapter 17. Physical therapy management of Benign Positional Vertigo. 3rd ed. In: Herdman SJ, editor. Vestibular Rehabilitation. Philadelphia, PA: F.A. Davis Company (2007). p. 233–64.
25. Ustun TB, Chatterji S, Bickenbach J, Kostanjsek N, Schneider M. The international classification of functioning, disability and health: a new tool for understanding disability and health. Disabil Rehabil (2003) 25(11–12):565–71. doi:10.1080/0963828031000137063
28. Maes L, Vinck BM, De Vel E, D’haenens W, Bockstael A, Keppler H, et al. The vestibular evoked myogenic potential: a test-retest reliability study. Neurophysiol Clin (2009) 120(3):594–600. doi:10.1016/j.clinph.2008.11.027
31. Dannenbaum E, Paquet N, Hakim-Zadeh R, Feldman AG. Optimal parameters for the clinical test of dynamic visual acuity in patients with a unilateral vestibular deficit. J Otolaryngol (2005) 34(1):13–9. doi:10.2310/7070.2005.03105
35. Agrell B, Dehlin O. Mini Mental State Examination in geriatric stroke patients. Validity, differences between subgroups of patients, and relationships to somatic and mental variables. Aging Clin Exp Res (2000) 12(6):439–44. doi:10.1007/BF03339874
37. McDowell I, Kristjansson B, Hill GB, Hébert R. Community screening for dementia: the Mini Mental State Exam (MMSE) and Modified Mini-Mental State Exam (3MS) compared. J Clin Epidemiol (1997) 50(4):377–83. doi:10.1016/S0895-4356(97)00060-7
38. Moster S, Wilson JA, Galetta SL, Balcer LJ. The King-Devick (K-D) test of rapid eye movements: a bedside correlate of disability and quality of life in MS. J Neurol Sci (2014) 343(1–2):105–9. doi:10.1016/j.jns.2014.05.047
41. Flansbjer UB, Blom J, Brogårdh C. The reproducibility of Berg Balance Scale and the Single-leg Stance in chronic stroke and the relationship between the two tests. PM R (2012) 4(3):165–70. doi:10.1016/j.pmrj.2011.11.004
42. Steffen Teresa M, Hacker Timothy A, Mollinger L. Age- and gender-related test performance in community-dwelling elderly people: six-minute walk test, berg balance scale, timed up & go test, and gait speeds. Phys Ther (2002) 82:128–37.
47. Aben I, Verhey F, Lousberg R, Lodder J, Honig A. Validity of the beck depression inventory, hospital anxiety and depression scale, SCL-90, and Hamilton depression rating scale as screening instruments for depression in stroke patients. Psychosomatics (2002) 43(5):386–93. doi:10.1176/appi.psy.43.5.386
48. Hallal PC, Simoes E, Reichert FF, Azevedo MR, Ramos LR, Pratt M, et al. Validity and reliability of the telephone-administered international physical activity questionnaire in Brazil. J Phys Act Health (2010) 7(3):402–9. doi:10.1123/jpah.7.3.402
49. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International Physical Activity Questionnaire (IPAQ): 12-country reliability and validity. Med Sci Sports Exerc (2003) 35:1381–95. doi:10.1249/01.MSS.0000078924.61453.FB
51. Herdman SJ, Whitney SL. Chapter 20. Interventions for the patient with vestibular hypofunction. 3rd ed. In: Herdman SJ, editor. Vestibular Rehabilitation. Philadelphia, PA: F.A. Davis Company (2007). p. 309–37.
Keywords: stroke, visual impairment, eye movement disorders, vestibular dysfunction, rehabilitation, physiotherapy, prevalence
Citation: van Wyk A, Eksteen CA, Becker PJ and Heinze BM (2016) A Cross-sectional Survey and Cross-sectional Clinical Trial to Determine the Prevalence and Management of Eye Movement Disorders and Vestibular Dysfunction in Post-Stroke Patients in the Sub-Acute Phase: Protocol. Front. Neurol. 7:140. doi: 10.3389/fneur.2016.00140
Received: 26 June 2016; Accepted: 15 August 2016;
Published: 20 September 2016
Edited by:Jose Antonio Lopez-Escamez, Granada University Hospital, Spain
Reviewed by:Jorge Kattah, University of Illinois College of Medicine Peoria, USA
Juan Carlos Amor-Dorado, IBSALUT, Spain
Copyright: © 2016 van Wyk, Eksteen, Becker and Heinze. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Andoret van Wyk, email@example.com